Apellis Pharmaceuticals, Inc. APLS
41.03 USD 0.00 (+0.00%)
At closeMay 15, 2026, 4:00 PM EDT
41.06 +0.03 +0.07%
After hours · May 15, 4:00 PM ET
41.03 Day range 41.05
52-week range unavailable
- YTD
- +63.34%
- 1 year
- +150.79%
News
reuters.com Biogen scales back Apellis programs, trims research roles after $5.6 billion buyout Biogen said on Friday it had either paused or discontinued funding for most of Apellis Pharmaceuticals' research programs as it integrates the rare-disease drugs specialist it purchased for $5.6…
gurufocus.com Pfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer [url="]Pfizer Inc. [/url](NYSE: PFE) today announced detailed progression-free and overall survival results from Cohort 3, a randomized cohort of the Phase 3 B
gurufocus.com TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer [url="]Pfizer Inc. [/url](NYSE: PFE) today announced detailed results from the pivotal Phase 3 TALAPRO-3 study of TALZENNAÂ (talazoparib), an oral poly ADP-ri
benzinga.com Why Is Biogen Stock Falling Thursday? Biogen shares slip after mixed Phase 2 Alzheimer's data, but analysts remain optimistic on diranersen's cognitive benefits.
benzinga.com Biogen Stock Gains Despite Extended FDA Review For Alzheimer's Therapy FDA extends review for Biogen's Leqembi Iqlik for early Alzheimer's disease to August 2026.
prnewswire.com Bright Horizons Family Solutions and Remitly Global Set to Join S&P SmallCap 600 NEW YORK, May 7, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P SmallCap 600 effective prior to the opening of trading on Thursday, May 14: Bright Horizons…
benzinga.com Remitly Global Set To Join S&P SmallCap 600 Will Replace Apellis Pharmaceuticals https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20260507-1483310/1483310_tph-apls-6.pdf
zacks.com Compared to Estimates, Apellis Pharmaceuticals (APLS) Q1 Earnings: A Look at Key Metrics The headline numbers for Apellis Pharmaceuticals (APLS) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to…
zacks.com Apellis Pharmaceuticals, Inc. (APLS) Tops Q1 Earnings and Revenue Estimates Apellis Pharmaceuticals, Inc. (APLS) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of a loss of $0.38 per share. This compares to a loss of $0.74 per share…
globenewswire.com $HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger—CZNL, HLX, APLS, and SLNO NEW YORK, May 05, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and…
benzinga.com Top 3 Health Care Stocks That May Collapse This Month Stocks AVNS, APLS, and CERS in healthcare sector flashing warning to momentum-sensitive investors. High RSI values & price action indicate overbought conditions. AVNS at 90. APLS at 86. CERS at 86.…
benzinga.com Tech Powers Nasdaq's Best Month Since 2020: These Stocks Are The Silent Performers The Nasdaq Composite surged 15.3% in April, marking its strongest monthly gain since the early pandemic, driven by AI-fueled tech earnings.
zacks.com Biogen Beats Q1 Earnings Estimates but Cuts 2026 EPS View on M&A Costs Biogen beats Q1 earnings and revenue estimates, fueled by new drug growth, but cuts 2026 EPS outlook to reflect M&A costs.
prnewswire.com Are CCO, EHAB, APLS, VRE Obtaining Fair Deals for their Shareholders? /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
businesswire.com Apellis Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apellis Pharmaceuticals, Inc. - APLS NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of…
globenewswire.com $HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger—KZR, FORA, SLNO, and APLS NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde and Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders…
prnewswire.com Are APLS, CNTA, KZR Obtaining Fair Deals for their Shareholders? /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
defenseworld.net Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Given Average Rating of “Hold” by Analysts Shares of Apellis Pharmaceuticals, Inc. (NASDAQ: APLS - Get Free Report) have received an average recommendation of "Hold" from the twenty-three brokerages that are currently covering the firm,…
globenewswire.com Shareholder Alert: Ademi LLP investigates whether Apellis Pharmaceuticals Inc. is obtaining a Fair Price for Public Shareholders MILWAUKEE, April 07, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Apellis (NASDAQ: APLS) for possible breaches of fiduciary duty and other violations of law in its recently announced…
feeds.benzinga.com Apellis Stock Soars After Biogen Deal, Momentum Score Surges—Here's What Shareholders Get Apellis jumps as Biogen agrees $5.6 Billion acquisition, offering $41/share plus milestones, boosting rare-disease portfolio.
benzinga.com Deal Dispatch: McCormick, Unilever Merge, Sysco Acquires Jetro Restaurant Depot For $29 Billion, QVC Considers Bankruptcy Major M&A deals this week include: Eli Lilly's $7.8 billion purchase of Centessa Pharmaceuticals; Meanwhile, IO Biotech goes bankrupt.
247wallst.com Here Are Thursday’s Top Wall Street Analyst Research Calls: Akamai Technologies, Astra-Zeneca, Brinker, e.l.f. Beauty, Freeport-McMoran, Vale, Wingstop, Wix.com, and More Pre-Market Stock Futures: Risk-on appeared back, at least for the last two days, as the stock market put together another rally on Wednesday, with hopes for an end to the war in Iran and some solid…
defenseworld.net Apellis Pharmaceuticals (NASDAQ:APLS) Hits New 52-Week High – Should You Buy? Shares of Apellis Pharmaceuticals, Inc. (NASDAQ: APLS - Get Free Report) hit a new 52-week high during trading on Tuesday. The stock traded as high as $40.43 and last traded at $40.41, with a volume…
prnewswire.com SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) NEW YORK, April 1, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is…
zacks.com Biogen to Acquire Apellis for $5.6B to Strengthen Immunology Portfolio BIIB's $5.6B offer to acquire APLS is set to add two key immunology drugs, boosting near-term revenues and strengthening its push into high-growth rare disease markets.
benzinga.com Scholar Rock To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday Top Wall Street analysts changed their outlook on top names. For a complete view of all rating changes, see analyst ratings page.
zacks.com Apellis Pharmaceuticals (APLS) Moves 135.4% Higher: Will This Strength Last? Apellis Pharmaceuticals (APLS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in…
benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session 
benzinga.com Gold Gains Over 1%; FactSet Research Raises FY2026 Outlook US stocks rise on Tuesday, with NASDAQ up 2% and Dow up 1.37%. Communication services shares gain 2.2%, while utilities fall 0.7%. FactSet reports upbeat Q2 results and raises outlook.
benzinga.com Apellis Pharmaceuticals, Centessa Pharmaceuticals, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday US stocks rise, Dow Jones gains 600+ pts. Apellis Pharma shares surge 136.4% after buyout by Biogen for $41/share. Other gainers incl. Centessa, Annexon, Agios, Fulcrum, Scholar Rock, Alkermes, Wave…
benzinga.com Dow Jumps 400 Points; TD Synnex Posts Upbeat Earnings US stocks higher, Dow up 0.90%, Nasdaq up 1.61%. Communication services gained 1.8%, utilities fell 0.6%. TD Synnex beats earnings estimates.
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session 
benzinga.com Earnings Scheduled For February 24, 2026 
benzinga.com Silver Jumps To $89 After Soft CPI, JPMorgan Falls 3%: What's Moving Markets Tuesday? Wall Street traded timidly on Tuesday despite another benign inflation report that reinforced expectations for Federal Reserve rate cuts later this year, as a weaker-than-expected start to the…
benzinga.com Five Below To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Tuesday 
benzinga.com Gold, Silver Spike To Record Highs As Fed Independence Falters: What's Moving Markets Monday? Gold and silver surged to fresh record highs Monday as investors reassessed the Federal Reserve's independence fears amid a new political escalation.
benzinga.com S&P 500 Hits New Record Highs, Alphabet Dethrones Apple: What's Moving Markets Wednesday? The S&P 500 pushed to fresh record highs during midday trading on Wednesday, extending a three-day rally and eyeing a fourth straight gain.
benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session 
benzinga.com Earnings Scheduled For October 30, 2025 
benzinga.com Concentrix Posts Downbeat Earnings, Joins Legacy Education, Kingsoft Cloud And Other Big Stocks Moving Lower In Friday's Pre-Market Session U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Friday.
benzinga.com Why Top KingWin Shares Are Trading Higher By 87%; Here Are 20 Stocks Moving Premarket Shares of Top KingWin Ltd (NASDAQ: WAI) rose sharply in pre-market trading after the company announced it entered into a sales contract with Walker Times International for the sale of 10,000 units of…
benzinga.com Roblox, Carvana, eBay, C.H. Robinson Worldwide, Huntington Ingalls Industries And Other Big Stocks Moving Higher On Thursday 
benzinga.com Earnings Scheduled For July 31, 2025 
benzinga.com Earnings Scheduled For May 7, 2025 - benzinga.com Earnings Scheduled For February 28, 2025
benzinga.com Mama's Creations Posts Weak Earnings, Joins EVgo, Red Cat Holdings And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session 
benzinga.com Celanese Posts Downbeat Results, Joins Cirrus Logic, Teradata And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session 
benzinga.com CrowdStrike To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Monday